| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |